1. Transitional cell carcinoma of the bladder: New approaches to the treatment of advanced disease

   • Daniel P. Petrylak

   Invited Commentary Pages: 285 - 286

2. Web alert

   News Pages: 287 - 287

3. Literature alert

   Abstract Pages: 288 - 290

4. Clinical Trials Report

   • Frank L. Meyskens Jr

   BriefCommunication Pages: 293 - 294

5. Prevention of non-melanoma skin cancer

   • Steven P. Stratton

   OriginalPaper Pages: 295 - 300

6. Retinoid mechanisms and cyclins

   • Jay O. Boyle

   OriginalPaper Pages: 301 - 305

7. Do antioxidants still have a role in the prevention of human cancer?

   • Mack T. Ruffin IV
   • Cheryl L. Rock

   OriginalPaper Pages: 306 - 313

8. Mammographic densities as a marker of human breast cancer risk and their use in chemoprevention

   • Norman F. Boyd
   • Lisa J. Martin
   • Martin J. Yaffe

   OriginalPaper Pages: 314 - 321

9. Prevention of cervical cancer with vaccines

   • Samuel S. Im
   • Bradley J. Monk
   • Luis P. Villarreal

   OriginalPaper Pages: 322 - 328

10. Antisense therapy for melanoma

    • Ernest C. Borden

    Clinical Trials Report Pages: 331 - 331

11. Review of the 2001 AJCC staging system for cutaneous malignant melanoma

    • Lynn M. Schuchter

    ReviewPaper Pages: 332 - 337

12. Autologous and allogeneic high-dose therapy for melanoma

    • Kim A. Margolin

    OriginalPaper Pages: 338 - 343

13. Targeted therapy for malignant melanoma

    • C. Komen Brown
    • John M. Kirkwood

    OriginalPaper Pages: 344 - 352

14. Angiogenesis and melanoma

    • Janice P. Dutcher

    OriginalPaper Pages: 353 - 358

15. Isolated limb perfusion for extremity soft-tissue sarcomas, in-transit metastases, and other unresectable tumors: Credits, debits, and future perspectives

    • Alexander M. M. Eggermont
    • Timo L. M. ten Hagen

    OriginalPaper Pages: 359 - 367

16. Transcription factors and other dysregulated proteins in melanoma prognosis

    • Jari M. Karjalainen

    OriginalPaper Pages: 368 - 375